Back to Search
ANDREW GODDARD, RPH
RPH
Pharmacist
NPI: 1205552833Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03122391(OH)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
2
With Results
The Role of Orexin in Human Panic Disorder
NCT02593682COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients
NCT00619892COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients
NCT00198094COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder.
PMID 26379759·Ann Gen Psychiatry·2015
8-other
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects.
PMID 25583879·J Pharmacol Exp Ther·2015
7-preclinical
The hypocretin/orexin system mediates the extinction of fear memories.
PMID 24930888·Neuropsychopharmacology·2014
7-preclinical
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
PMID 24680372·Lancet Neurol·2014
3-trial
Increased resting-state functional connectivity between the anterior cingulate cortex and the precuneus in panic disorder: resting-state connectivity in panic disorder.
PMID 23688914·J Affect Disord·2013
8-other
Decreased GABA levels in anterior cingulate cortex/medial prefrontal cortex in panic disorder.
PMID 23391588·Prog Neuropsychopharmacol Biol Psychiatry·2013
8-other
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.
PMID 23372274·Sleep·2013
2-rct
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
PMID 23197752·Neurology·2012
4-observational
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.
PMID 22453138·Neuropsychopharmacology·2012
7-preclinical
Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder.
PMID 20116928·Psychoneuroendocrinology·2010
8-other
Current perspectives of the roles of the central norepinephrine system in anxiety and depression.
PMID 19960531·Depress Anxiety·2010
6-review
Neural pathways underlying lactate-induced panic.
PMID 18059441·Neuropsychopharmacology·2008
7-preclinical
Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.
PMID 18160631·J Neurosci·2007
7-preclinical
Control of hypothalamic orexin neurons by acid and CO2.
PMID 17563364·Proc Natl Acad Sci U S A·2007
7-preclinical
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
PMID 17346943·Eur Neuropsychopharmacol·2007
8-other
Characterization of the promoter of the mouse preproorexin gene.
PMID 17341811·Biosci Biotechnol Biochem·2007
7-preclinical
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.
PMID 17299454·Nat Rev Neurosci·2007
6-review
A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study.
PMID 14570674·Anesth Analg·2003
3-trial
LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress.
PMID 13129812·Stress·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 736 REDWOOD DR
CANAL FULTON, OH 44614 - Phone
- (330) 309-0197
Quick Facts
- NPI
- 1205552833
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile